25Schools
University revision · Toxicology and Pharmacology

Hormonal Therapy, Drug Resistance, and Toxicity in Oncology

This advanced topic addresses critical concepts in cancer management for university-level pharmacology and medical students in Zambia. It covers the principles of hormonal therapy for breast and prostate cancer, including drugs like tamoxifen, aromatase inhibitors, and anti-androgens. The module then explores the major challenge of drug resistance, detailing mechanisms such as de novo resistance, acquired mutations, and multidrug resistance (MDR) mediated by P-glycoprotein. Finally, it provides a comprehensive overview of the systemic toxicity of anticancer drugs, focusing on effects on bone marrow, gastrointestinal epithelium, and hair follicles. For Zambian learners, understanding these limitations of chemotherapy is crucial for developing realistic treatment plans, managing patient expectations, and contributing to research aimed at overcoming resistance and reducing toxicity in cancer care within resource-limited settings.

Questions
100
Est. time
~100 min
Views
0
Pass mark
50%

How this revision works

Outcomes

If you passImpressive work! Grasping the nuances of hormonal therapy, the complex mechanisms of resistance, and the spectrum of drug toxicities shows you are thinking like an oncologist. This integrative knowledge is key for advanced clinical practice and research in your field.
If you don't pass yetThe concepts of resistance and broad-spectrum toxicity are central to modern oncology. Review the different types of resistance (de novo, acquired, MDR) and map the common toxicities to the affected rapidly dividing tissues. This will enhance your ability to evaluate treatment challenges.

More in this course